Red cell distribution width related to the severity of the disease in patients with AECOPD.

IF 1.9 4区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Biomarkers in medicine Pub Date : 2025-03-01 Epub Date: 2025-03-12 DOI:10.1080/17520363.2025.2468152

Yiben Huang, Jianing Wang, Siyao Chen, Zicong Dai, Xuanyang Chen, Xinran Li, Ruizi Xu, Beibei Yu, Chunyan Liu, Xianjing Chen, Pengfei Zhang, Yage Xu, Xiaodiao Zhang

{"title":"Red cell distribution width related to the severity of the disease in patients with AECOPD.","authors":"Yiben Huang, Jianing Wang, Siyao Chen, Zicong Dai, Xuanyang Chen, Xinran Li, Ruizi Xu, Beibei Yu, Chunyan Liu, Xianjing Chen, Pengfei Zhang, Yage Xu, Xiaodiao Zhang","doi":"10.1080/17520363.2025.2468152","DOIUrl":null,"url":null,"abstract":"Aims: This research aims to elucidate the association between red cell distribution width (RDW) and the severity of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).Patients & methods: This retrospective study enrolled patients with AECOPD and healthy controls. A comprehensive meta-analysis was further conducted by systematically searching PubMed, Embase, and the Cochrane Library up to 27 April 2023.Results: Univariate logistic regression analysis indicated that elevated RDW levels were significantly associated with AECOPD (p = 0.016). The pooled results yielded a diagnostic sensitivity of 0.76 (95% CI: 0.70-0.81) and specificity of 0.53 (95% CI: 0.38-0.68) for RDW in predicting AECOPD severity.Conclusion: Elevated RDW levels exhibit a linear positive correlation with AECOPD severity, further supported by meta-analysis.","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":"19 5","pages":"177-186"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11916365/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers in medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17520363.2025.2468152","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: This research aims to elucidate the association between red cell distribution width (RDW) and the severity of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Patients & methods: This retrospective study enrolled patients with AECOPD and healthy controls. A comprehensive meta-analysis was further conducted by systematically searching PubMed, Embase, and the Cochrane Library up to 27 April 2023.

Results: Univariate logistic regression analysis indicated that elevated RDW levels were significantly associated with AECOPD (p = 0.016). The pooled results yielded a diagnostic sensitivity of 0.76 (95% CI: 0.70-0.81) and specificity of 0.53 (95% CI: 0.38-0.68) for RDW in predicting AECOPD severity.

Conclusion: Elevated RDW levels exhibit a linear positive correlation with AECOPD severity, further supported by meta-analysis.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Biomarkers in medicine 医学-医学：研究与实验

CiteScore

3.80

自引率

4.50%

发文量

审稿时长

6-12 weeks

期刊介绍： Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory. Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications. Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest. Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.